World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
78
Citations
56094
World Ranking
4427
National Ranking
2149

Hans-Peter Gerber publication distribution in Biology and Biochemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Hans-Peter Gerber sits on this spectrum.

47–56 publications: 8 scientists 57–66 publications: 35 scientists 67–76 publications: 106 scientists 77–86 publications: 231 scientists 87–96 publications: 414 scientists 97–106 publications: 546 scientists 107–116 publications: 704 scientists 117–126 publications: 849 scientists 127–136 publications: 980 scientists 137–146 publications: 942 scientists 147–156 publications: 969 scientists 157–166 publications: 950 scientists 167–176 publications: 951 scientists 177–186 publications: 915 scientists 187–196 publications: 787 scientists 197–206 publications: 841 scientists 207–216 publications: 735 scientists 217–226 publications: 709 scientists 227–236 publications: 651 scientists 237–246 publications: 605 scientists 247–256 publications: 510 scientists 257–266 publications: 524 scientists 267–276 publications: 434 scientists 277–286 publications: 418 scientists 287–296 publications: 350 scientists 297–306 publications: 363 scientists 307–316 publications: 315 scientists 317–326 publications: 296 scientists 327–336 publications: 261 scientists 337–346 publications: 240 scientists 347–356 publications: 219 scientists 357–366 publications: 197 scientists 367–376 publications: 154 scientists 377–386 publications: 161 scientists 387–396 publications: 155 scientists 397–406 publications: 145 scientists 407–416 publications: 124 scientists 417–426 publications: 112 scientists 427–436 publications: 132 scientists 437–446 publications: 116 scientists 447–456 publications: 99 scientists 457–466 publications: 81 scientists 467–476 publications: 91 scientists 477–486 publications: 80 scientists 487–496 publications: 80 scientists 497–506 publications: 60 scientists 507–516 publications: 36 scientists 517–526 publications: 46 scientists 527–536 publications: 54 scientists 537–546 publications: 44 scientists 547–556 publications: 43 scientists 557–566 publications: 43 scientists 567–576 publications: 42 scientists 577–586 publications: 25 scientists 587–596 publications: 34 scientists 597–606 publications: 23 scientists 607–616 publications: 33 scientists 617–626 publications: 31 scientists 627–636 publications: 27 scientists 637–646 publications: 25 scientists 647–656 publications: 28 scientists 657–666 publications: 34 scientists 667–676 publications: 18 scientists 677–686 publications: 16 scientists 687–696 publications: 10 scientists 697–706 publications: 12 scientists 707–716 publications: 21 scientists 717–726 publications: 12 scientists 727–736 publications: 12 scientists 737–746 publications: 10 scientists 747–756 publications: 7 scientists 757–766 publications: 13 scientists 767–776 publications: 15 scientists 777–786 publications: 13 scientists 787–796 publications: 9 scientists 797–806 publications: 9 scientists 807–816 publications: 7 scientists 817–826 publications: 4 scientists 827–836 publications: 9 scientists 837–846 publications: 7 scientists 847–856 publications: 3 scientists 857–866 publications: 5 scientists 867–876 publications: 5 scientists 877–886 publications: 11 scientists 887–896 publications: 3 scientists 897–906 publications: 4 scientists 907–916 publications: 7 scientists 917–926 publications: 5 scientists 927–936 publications: 6 scientists 937–946 publications: 6 scientists 947–956 publications: 3 scientists 957–966 publications: 7 scientists 967–976 publications: 2 scientists 977–986 publications: 2 scientists 987–996 publications: 1 scientists 997–1,006 publications: 5 scientists 1,007–1,016 publications: 2 scientists 1,017–1,026 publications: 2 scientists 1,027 publications: 1 scientists 1,028+ publications: 100 scientists
47 publications 1,028+

This scientist: 181 publications — 42nd percentile

42% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,028 publications or more.

Hans-Peter Gerber D-index placement in Biology and Biochemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Hans-Peter Gerber sits on this spectrum.

40–41 D-Index: 80 scientists 42–43 D-Index: 183 scientists 44–45 D-Index: 317 scientists 46–47 D-Index: 504 scientists 48–49 D-Index: 718 scientists 50–51 D-Index: 900 scientists 52–53 D-Index: 1,026 scientists 54–55 D-Index: 1,150 scientists 56–57 D-Index: 1,236 scientists 58–59 D-Index: 1,253 scientists 60–61 D-Index: 1,163 scientists 62–63 D-Index: 1,131 scientists 64–65 D-Index: 1,032 scientists 66–67 D-Index: 897 scientists 68–69 D-Index: 814 scientists 70–71 D-Index: 715 scientists 72–73 D-Index: 709 scientists 74–75 D-Index: 596 scientists 76–77 D-Index: 512 scientists 78–79 D-Index: 473 scientists 80–81 D-Index: 412 scientists 82–83 D-Index: 373 scientists 84–85 D-Index: 358 scientists 86–87 D-Index: 285 scientists 88–89 D-Index: 273 scientists 90–91 D-Index: 227 scientists 92–93 D-Index: 208 scientists 94–95 D-Index: 193 scientists 96–97 D-Index: 153 scientists 98–99 D-Index: 157 scientists 100–101 D-Index: 148 scientists 102–103 D-Index: 120 scientists 104–105 D-Index: 113 scientists 106–107 D-Index: 100 scientists 108–109 D-Index: 86 scientists 110–111 D-Index: 67 scientists 112–113 D-Index: 72 scientists 114–115 D-Index: 73 scientists 116–117 D-Index: 64 scientists 118–119 D-Index: 53 scientists 120–121 D-Index: 60 scientists 122–123 D-Index: 54 scientists 124–125 D-Index: 43 scientists 126–127 D-Index: 38 scientists 128–129 D-Index: 49 scientists 130–131 D-Index: 26 scientists 132–133 D-Index: 18 scientists 134–135 D-Index: 23 scientists 136–137 D-Index: 32 scientists 138–139 D-Index: 32 scientists 140–141 D-Index: 27 scientists 142–143 D-Index: 19 scientists 144–145 D-Index: 22 scientists 146–147 D-Index: 12 scientists 148–149 D-Index: 16 scientists 150–151 D-Index: 14 scientists 152–153 D-Index: 10 scientists 154–155 D-Index: 13 scientists 156–157 D-Index: 10 scientists 158–159 D-Index: 7 scientists 160–161 D-Index: 9 scientists 162–163 D-Index: 13 scientists 164–165 D-Index: 4 scientists 166 D-Index: 4 scientists 167+ D-Index: 98 scientists
40 D-Index 167+

This scientist: 78 D-Index — 77th percentile

77% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 167 D-Index or more.

Overview

Hans-Peter Gerber is affiliated with Seattle Genetics in the United States. Their research primarily spans the field of Medicine, with a notable focus on Oncology, Immunology, Radiology, Nuclear Medicine and Imaging, Immunology and Allergy, and Hematology as subfields of study.

Their work is concentrated around several main topics, including:

  • CAR-T cell therapy research
  • Immunotherapy and Immune Responses
  • HER2/EGFR in Cancer Research
  • Cancer Immunotherapy and Biomarkers
  • Cell Adhesion Molecules Research
  • Monoclonal and Polyclonal Antibodies Research
  • Lung Cancer Treatments and Mutations

Frequent coauthors with whom Hans-Peter Gerber has collaborated are:

  • Christopher J. O'Donnell
  • Krishna Bajjuri
  • Cuong Tran
  • Gang Yin
  • Alice Yam

The scientist has published multiple papers across several venues. Frequent publication venues include:

  • Molecular Cancer Therapeutics
  • Cancer Research
  • Cell Reports Medicine
  • mAbs
  • Clinical Cancer Research

Recent papers authored or coauthored by Hans-Peter Gerber include:

  • "PF-06804103, A Site-specific Anti-HER2 Antibody-Drug Conjugate for the Treatment of HER2-expressing Breast, Gastric, and Lung Cancers" (2020) in Molecular Cancer Therapeutics
  • "NOTCH3-targeted antibody drug conjugates regress tumors by inducing apoptosis in receptor cells and through transendocytosis into ligand cells" (2021) in Cell Reports Medicine
  • "Anti-Extra Domain B Splice Variant of Fibronectin Antibody-Drug Conjugate Eliminates Tumors with Enhanced Efficacy When Combined with Checkpoint Blockade" (2022) in Molecular Cancer Therapeutics
  • "Therapeutic index improvement of antibody-drug conjugates" (2023) in mAbs
  • "Development of Highly Optimized Antibody-Drug Conjugates against CD33 and CD123 for Acute Myeloid Leukemia" (2020) in Clinical Cancer Research

Best Publications

  • The biology of VEGF and its receptors.

    Napoleone Ferrara;Hans-Peter Gerber;Jennifer LeCouter

  • Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer

    Napoleone Ferrara;Kenneth J. Hillan;Hans-Peter Gerber;William Novotny

  • Vascular Endothelial Growth Factor Regulates Endothelial Cell Survival through the Phosphatidylinositol 3′-Kinase/Akt Signal Transduction Pathway REQUIREMENT FOR Flk-1/KDR ACTIVATION

    Hans Peter Gerber;Amy McMurtrey;Joe Kowalski;Minhong Yan

  • VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation.

    Hans-Peter Gerber;Thiennu H. Vu;Anne M. Ryan;Joe Kowalski

  • HIF-1α Is Essential for Myeloid Cell-Mediated Inflammation

    Thorsten Cramer;Yuji Yamanishi;Björn E Clausen;Irmgard Förster

  • VEGF inhibition and renal thrombotic microangiopathy.

    Vera Eremina;J. Ashley Jefferson;Jolanta Kowalewska;Howard Hochster

  • Glomerular-specific alterations of VEGF-A expression lead to distinct congenital and acquired renal diseases

    Vera Eremina;Manish Sood;Jody Haigh;András Nagy

  • Vascular Endothelial Growth Factor Induces Expression of the Antiapoptotic Proteins Bcl-2 and A1 in Vascular Endothelial Cells

    Hans-Peter Gerber;Vishva Dixit;Napoleone Ferrara

  • VEGF is required for growth and survival in neonatal mice

    Hans-Peter Gerber;Kenneth J. Hillan;Anne M. Ryan;Joe Kowalski

  • Differential transcriptional regulation of the two vascular endothelial growth factor receptor genes : Flt-1, but not Flk-1/KDR, is up-regulated by hypoxia

    Hans-Peter Gerber;Fabrizio Condorelli;Jeanie Park;Napoleone Ferrara

  • Arterial Thromboembolic Events in Patients with Metastatic Carcinoma Treated with Chemotherapy and Bevacizumab

    Frank A. Scappaticci;Jamey R. Skillings;Scott N. Holden;Hans Peter Gerber

  • Tumor refractoriness to anti-VEGF treatment is mediated by CD11b + Gr1 + myeloid cells

    Farbod Shojaei;Xiumin Wu;Ajay K Malik;Cuiling Zhong

  • VEGF regulates haematopoietic stem cell survival by an internal autocrine loop mechanism

    Hans-Peter Gerber;Ajay K. Malik;Gregg P. Solar;Daniel Sherman

  • Vascular endothelial growth factor is essential for corpus luteum angiogenesis

    Napoleone Ferrara;Helen Chen;Terri Davis-Smyth;Hans-Peter Gerber

  • Corneal avascularity is due to soluble VEGF receptor-1

    Balamurali K. Ambati;Miho Nozaki;Nirbhai Singh;Atsunobu Takeda

  • Vascular Endothelial Growth Factor Molecular and Biological Aspects

    Napoleone Ferrara;Hans Peter Gerber

  • Angiogenesis-independent endothelial protection of liver: role of VEGFR-1.

    Jennifer LeCouter;Dirk R. Moritz;Bing Li;Gail Lewis Phillips

  • Pharmacology and pharmacodynamics of bevacizumab as monotherapy or in combination with cytotoxic therapy in preclinical studies.

    Hans-Peter Gerber;Napoleone Ferrara

  • Transcriptional activation modulated by homopolymeric glutamine and proline stretches.

    Hans-Peter Gerber;Katja Seipel;Oleg Georgiev;Manuela Höfferer

  • The vascular basement membrane: a niche for insulin gene expression and Beta cell proliferation.

    Ganka Nikolova;Normund Jabs;Irena Konstantinova;Anna Domogatskaya

Frequent Co-Authors

Napoleone Ferrara
Napoleone Ferrara University of California, San Diego
Germaine Fuh
Germaine Fuh Genentech
Audrey Goddard
Audrey Goddard Gilead Sciences
Dan L. Eaton
Dan L. Eaton Genentech
Wei-Qiang Gao
Wei-Qiang Gao Shanghai Jiao Tong University
Christian Wiesmann
Christian Wiesmann Novartis (Switzerland)
Sachdev S. Sidhu
Sachdev S. Sidhu University of Waterloo

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Biology and Biochemistry can open doors to a variety of rewarding healthcare professions. If you’re looking for flexible education options, there are numerous online programs that cater to different interests and career goals in allied health sciences.

For students interested in imaging and diagnostics, programs like online ultrasound tech school and rad tech online programs offer training that leads to in-demand roles in hospitals and clinics. These courses are designed for both newcomers and those seeking to expand their skill set.

Nutrition and wellness is another rapidly growing field. Earning a degree through one of the top dietetics masters programs can prepare you to become a registered dietitian or nutritionist, supporting individuals and communities toward healthier lifestyles.

If you’re looking for entry into healthcare, accredited medical assistant programs online michigan combine affordability with the flexibility to study from home. These programs often include financial aid options and hands-on training to help graduates launch their careers quickly.

Best Scientists Citing Hans-Peter Gerber

Trending Scientists

Recently Published Articles